MetaCap

Mentari Therapeutics Inc. Company Profile

NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.545 (-3.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Mentari Therapeutics at a glance

Mentari Therapeutics Inc. (NASDAQ: MTRI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Sacramento, CA, Canada. Mentari Therapeutics is led by Mr. Gregory J. Divis Jr.. At a market capitalization of $856.9 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001728328, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Mentari Therapeutics do?

Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.

Business description based on the company's public filings.

Company information

Legal name
Mentari Therapeutics Inc.
Ticker
NASDAQ: MTRI
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Gregory J. Divis Jr.
Headquarters
1625 North Market Blvd., Sacramento, CA, Canada
Phone
(916) 445-1254
Market cap
$856.94M
SEC CIK
0001728328
Latest annual report
10-K · Sep 9, 2026

Companies similar to Mentari Therapeutics

MTRI peer companies
CompanyPrice% ChgMarket capCompare
LTGOLatigo Biotherapeutics Inc.13.00-1.81%$861.89Mvs MTRI
PHARPharming Group N.V. ADS11.54-5.10%$816.78Mvs MTRI
CRVSCorvus Pharmaceuticals Inc.9.67-3.40%$815.69Mvs MTRI
AKTSAktis Oncology Inc.16.15-1.52%$901.14Mvs MTRI
VSTMVerastem Inc.6.33-7.73%$797.67Mvs MTRI
SNDXSyndax Pharmaceuticals Inc.8.72-4.49%$785.05Mvs MTRI
IRWDIronwood Pharmaceuticals Inc. Class A4.70-0.21%$778.09Mvs MTRI
SVRASavara Inc.4.26-18.23%$939.86Mvs MTRI

Related